Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2005, p. 1213-1215, Vol. 49, No. 3
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.3.1213-1215.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Division of Clinical Research, National Health Research Institutes,1 Graduate Institute of Life Sciences, National Defense Medical Center,2 Institute for Neuroscience, School of Life Sciences, National Yang-Ming University, Taipei,5 Department of Computer and Information Science,3 Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan, Republic of China4
Received 6 October 2004/ Returned for modification 26 October 2004/ Accepted 14 November 2004
The ERG3 gene in Candida albicans was identified as a gene whose mRNA level was higher in the cph1/cph1 efg1/efg1 double mutant than in the wild-type cells. Further study showed that Efg1, but not Cph1, negatively regulated ERG3. Mutations in EFG1 consistently increased the susceptibility of the cells to antifungal agents.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»